Search Results - D. I. Shikhbabaeva
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study by O. Yu. Vinogradova, M. M. Pankraskina, A. L. Neverova, D. I. Shikhbabaeva, M. A. Murzabekova, M. V. Chernikov, A. V. Popova, V. P. Kosenkova, L. B. Egoryan, V. V. Ptushkin
Published 2024-09-01
Article -
8
Efficacy of the combination of venetoclax and hypomethylating agents in the treatment of patients with primary, relapsed and/or refractory acute myeloid leukemia by E. V. Usikova, K. D. Kaplanov, V. I. Vorob'ev, T. I. Lobanova, M. A. Ul'yanova, D. G. Kisilichina, Yu. N. Kobzev, D. I. Shikhbabaeva, O. Yu. Vinogradova, V. V. Ptushkin
Published 2023-01-01
Article -
9
Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study by O. Yu. Vinogradova, D. I. Shikhbabaeva, Yu. N. Kobzev, A. L. Neverova, M. M. Pankraskina, S. G. Malakho, M. V. Chernikov, M. A. Murzabekova, A. G. Popova, L. B. Egoryan, A. V. Krechetova, V. V. Ptushkin
Published 2023-12-01
Article